Clinical Trial Update: Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of nifekalant hydrochloride injection for ventricular tachycardia and ventricular fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Fibrillation
• Ventricular Tachycardia

Drugs mentioned

• Nifekalant hydrochloride (Nifekalant hydrochloride)

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Ventricular Tachycardia, Ventricular Fibrillation | Phase 4 | Status: UNKNOWN